173 related articles for article (PubMed ID: 17607306)
1. Mining gene expression profiles: expression signatures as cancer phenotypes.
Nevins JR; Potti A
Nat Rev Genet; 2007 Aug; 8(8):601-9. PubMed ID: 17607306
[TBL] [Abstract][Full Text] [Related]
2. A pathway-based approach to identify molecular biomarkers in cancer.
Stevenson M; Potti A
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S620-4. PubMed ID: 22048630
[TBL] [Abstract][Full Text] [Related]
3. Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.
Anguiano A; Potti A
Expert Rev Mol Diagn; 2007 Nov; 7(6):837-44. PubMed ID: 18020912
[TBL] [Abstract][Full Text] [Related]
4. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
Glinsky GV
J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
[TBL] [Abstract][Full Text] [Related]
5. New gene selection method for multiclass tumor classification by class centroid.
Shen Q; Shi WM; Kong W
J Biomed Inform; 2009 Feb; 42(1):59-65. PubMed ID: 18835752
[TBL] [Abstract][Full Text] [Related]
6. Comparing solid tumors with cell lines: implications for identifying drug resistance genes in cancer.
Szakács G; Gottesman MM
Mol Interv; 2004 Dec; 4(6):323-5. PubMed ID: 15616161
[TBL] [Abstract][Full Text] [Related]
7. Gene-expression signatures of nasal polyps associated with chronic rhinosinusitis and aspirin-sensitive asthma.
Platt M; Metson R; Stankovic K
Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):23-8. PubMed ID: 19532090
[TBL] [Abstract][Full Text] [Related]
8. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.
Carter SL; Eklund AC; Kohane IS; Harris LN; Szallasi Z
Nat Genet; 2006 Sep; 38(9):1043-8. PubMed ID: 16921376
[TBL] [Abstract][Full Text] [Related]
9. Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.
Braconi C; Meng F; Swenson E; Khrapenko L; Huang N; Patel T
Cancer; 2009 Aug; 115(16):3738-48. PubMed ID: 19514085
[TBL] [Abstract][Full Text] [Related]
10. Utilization of genomic signatures to direct use of primary chemotherapy.
Potti A; Nevins JR
Curr Opin Genet Dev; 2008 Feb; 18(1):62-7. PubMed ID: 18339540
[TBL] [Abstract][Full Text] [Related]
11. Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.
Buys TP; Chari R; Lee EH; Zhang M; MacAulay C; Lam S; Lam WL; Ling V
Genes Chromosomes Cancer; 2007 Dec; 46(12):1069-79. PubMed ID: 17726699
[TBL] [Abstract][Full Text] [Related]
12. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
Lancashire LJ; Rees RC; Ball GR
Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
[TBL] [Abstract][Full Text] [Related]
13. Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation.
Tang ZQ; Han LY; Lin HH; Cui J; Jia J; Low BC; Li BW; Chen YZ
Cancer Res; 2007 Oct; 67(20):9996-10003. PubMed ID: 17942933
[TBL] [Abstract][Full Text] [Related]
14. Tumor classification ranking from microarray data.
Hewett R; Kijsanayothin P
BMC Genomics; 2008 Sep; 9 Suppl 2(Suppl 2):S21. PubMed ID: 18831787
[TBL] [Abstract][Full Text] [Related]
15. Dynamic alteration of gene expression induced by anticancer-agent exposure in gastric cancer cell lines.
Takahashi T; Saikawa Y; Nakamura R; Kumagai K; Takeuchi H; Kubota T; Kitagawa Y
Oncol Rep; 2009 Feb; 21(2):451-9. PubMed ID: 19148522
[TBL] [Abstract][Full Text] [Related]
16. Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors.
Kela I; Harmelin A; Waks T; Orr-Urtreger A; Domany E; Eshhar Z
Prostate; 2009 Jul; 69(10):1034-44. PubMed ID: 19343735
[TBL] [Abstract][Full Text] [Related]
17. Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model.
Rhee DK; Park SH; Jang YK
Genomics; 2008 Dec; 92(6):419-28. PubMed ID: 18804527
[TBL] [Abstract][Full Text] [Related]
18. Identification of gene signatures for invasive colorectal tumor cells.
Wiese AH; Auer J; Lassmann S; Nährig J; Rosenberg R; Höfler H; Rüger R; Werner M
Cancer Detect Prev; 2007; 31(4):282-95. PubMed ID: 17936523
[TBL] [Abstract][Full Text] [Related]
19. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
20. A SLAMS dunk for cancer regulators.
Kumar-Sinha C; Chinnaiyan AM
Nat Biotechnol; 2006 May; 24(5):524-6. PubMed ID: 16680134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
